Ovid Therapeutics Inc.

OVID

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001636651

SEC filings (opens in a new tab)

No open-market purchases or sales by Ovid Therapeutics Inc. insiders were filed in the last 90 days; 130 institutions reported holding it in 13F filings for Q2 2026, worth $395.5M in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Ovid Therapeutics Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026 All holders in Q4 2025

13F holders of OVID: Q4 2025 compared with Q1 2026
Measure	Q4 2025	Of which not filed for Q1 2026	Q1 2026	Change
Holders	84	1	103	+20
Shares	61.8M	3.07M	105.1M	+46.4M (+79.0%)
Value	$100.2M	$5.01M	$233.2M	+$138.0M (+145.0%)

1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (30)

Institutions that held Ovid Therapeutics Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to OVID in Q1 2026
Institution	Shares	Value	% of portfolio
Janus Henderson Group PLC	10,714,000	$23.7M	0.01%
Vanguard Capital Management LLC	5,258,246	$11.7M	0.00%
Blue Owl Capital Holdings LP	1,904,666	$4.23M	1.14%
Sphera Funds Management Ltd.	1,622,828	$3.60M	0.62%
Rosalind Advisors, Inc.	1,107,994	$2.46M	1.01%
Silverarc Capital Management, LLC	1,000,000	$2.22M	0.26%
Propel Bio Management, LLC	921,457	$2.04M	1.28%
Vanguard Fiduciary Trust Co	693,256	$1.54M	0.00%
SEI Investments Co	328,924	$730.2K	0.00%
EAM Investors, LLC	270,298	$600.1K	0.07%
CIBC World Markets Inc.	249,351	$553.6K	0.00%
Verdad Advisers, LP	151,919	$337.3K	0.38%
Simplify Asset Management Inc.	130,813	$290.4K	0.00%
Brevan Howard Capital Management LP	101,759	$225.9K	0.00%
Empowered Funds, LLC	91,234	$202.5K	0.00%
Axq Capital, LP	85,411	$189.6K	0.02%
Charles Schwab Investment Management Inc	72,000	$159.8K	0.00%
Diametric Capital, LP	43,262	$96.0K	0.03%
Mangrove Partners	27,294	$60.6K	0.00%
Two Sigma Securities, LLC	25,324	$56.2K	0.01%
Vanguard Global Advisers, LLC	23,739	$52.7K	0.00%
State of Wyoming	22,171	$49.2K	0.01%
Buckingham Strategic Partners	20,000	$44.4K	0.00%
Group One Trading, L.P.	13,246	$29.4K	0.00%
Victory Capital Management Inc	13,166	$29.2K	0.00%
Prelude Capital Management, LLC	10,951	$24.3K	0.00%
Caitong International Asset Management Co., Ltd	4,384	$9.73K	0.00%
Jones Financial Companies LLLP	2,925	$6.73K	0.00%
Fortitude Family Office, LLC	312	$693	0.00%
Advisory Services Network, LLC	219	$486	0.00%

Sold out (10)

Institutions that held Ovid Therapeutics Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of OVID in Q1 2026
Institution	Shares, Q4 2025	Value, Q4 2025
Acadian Asset Management LLC	1,231,698	$2.01M
AWM Investment Company, Inc.	899,200	$1.47M
Two Sigma Advisers, LP	239,200	$389.9K
Graham Capital Management, L.P.	127,459	$207.8K
Nine Masts Capital Ltd	13,960	$22.8K
Tower Research Capital LLC (TRC)	10,676	$17.4K
Sepio Capital, LP	10,145	$16.5K
North Star Investment Management Corp.	1,043	$1.70K
Tradewinds Capital Management, LLC	100	$163
SageView Advisory Group, LLC	44	$72

Not filed for Q1 2026 yet (1)

Institutions that held Ovid Therapeutics Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding OVID in Q4 2025 that haven't filed for Q1 2026
Institution	Shares, Q4 2025	Value, Q4 2025
Vanguard Group Inc	3,072,227	$5.01M